IL165989A0 - Process for producing a virus-inactivated thrombinpreparation - Google Patents

Process for producing a virus-inactivated thrombinpreparation

Info

Publication number
IL165989A0
IL165989A0 IL16598903A IL16598903A IL165989A0 IL 165989 A0 IL165989 A0 IL 165989A0 IL 16598903 A IL16598903 A IL 16598903A IL 16598903 A IL16598903 A IL 16598903A IL 165989 A0 IL165989 A0 IL 165989A0
Authority
IL
Israel
Prior art keywords
virus
thrombinpreparation
inactivated
producing
processes
Prior art date
Application number
IL16598903A
Other languages
English (en)
Original Assignee
Nat Blood Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Blood Authority filed Critical Nat Blood Authority
Publication of IL165989A0 publication Critical patent/IL165989A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16598903A 2002-07-10 2003-07-07 Process for producing a virus-inactivated thrombinpreparation IL165989A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216002.6A GB0216002D0 (en) 2002-07-10 2002-07-10 Process and composition
PCT/GB2003/002942 WO2004007707A1 (en) 2002-07-10 2003-07-07 Process for producing a virus-inactivated thrombin preparation

Publications (1)

Publication Number Publication Date
IL165989A0 true IL165989A0 (en) 2006-01-15

Family

ID=9940204

Family Applications (3)

Application Number Title Priority Date Filing Date
IL16598903A IL165989A0 (en) 2002-07-10 2003-07-07 Process for producing a virus-inactivated thrombinpreparation
IL165989A IL165989A (en) 2002-07-10 2004-12-26 Process for producing a virus-inactivated thrombin preparation
IL201146A IL201146A (en) 2002-07-10 2009-09-23 A process for preparing a thrombin preparation in which the viruses have been taken out of action

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL165989A IL165989A (en) 2002-07-10 2004-12-26 Process for producing a virus-inactivated thrombin preparation
IL201146A IL201146A (en) 2002-07-10 2009-09-23 A process for preparing a thrombin preparation in which the viruses have been taken out of action

Country Status (19)

Country Link
US (1) US8435779B2 (xx)
EP (1) EP1520018B1 (xx)
JP (1) JP4445386B2 (xx)
AT (1) ATE354648T1 (xx)
AU (1) AU2003244858B2 (xx)
BR (1) BRPI0312522B8 (xx)
CA (1) CA2491718C (xx)
CY (1) CY1107632T1 (xx)
DE (1) DE60311990T2 (xx)
EC (1) ECSP055586A (xx)
ES (1) ES2282644T3 (xx)
GB (1) GB0216002D0 (xx)
IL (3) IL165989A0 (xx)
MX (1) MXPA05000393A (xx)
NO (1) NO20050090L (xx)
NZ (1) NZ537502A (xx)
PL (1) PL208219B1 (xx)
PT (1) PT1520018E (xx)
WO (1) WO2004007707A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2572327A1 (en) * 2004-06-29 2006-02-02 Reliance Life Sciences Pvt. Ltd. Process for the preparation of virus-safe biological fluids
EP1685852A1 (en) * 2005-02-01 2006-08-02 Fondation pour la Recherche Diagnostique Set of disposable bags for viral inactivation of biological fluids
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
US20070148151A1 (en) 2005-07-29 2007-06-28 Martin Frink Processes for the manufacture and use of pancreatin
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
PL2027263T3 (pl) * 2006-05-22 2013-01-31 Abbott Laboratories Gmbh Sposób separacji i określenia wiremii w próbce pankreatyny
US7774628B2 (en) * 2006-05-25 2010-08-10 Foundry Networks, Inc. Enabling/disabling power-over-ethernet software subsystem in response to power supply status
KR20100134078A (ko) * 2008-04-16 2010-12-22 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 트롬빈 고정화 생체 흡수성 시트 제제의 제조방법
JP5442310B2 (ja) * 2009-04-23 2014-03-12 旭化成メディカル株式会社 トロンビン溶液の調製方法
US8945895B2 (en) * 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
AU2015252061A1 (en) * 2009-07-31 2015-11-19 Baxalta GmbH Method for Purifying Recombinant ADAMTS13 and Other Proteins and Compositions Thereof
SE1050124A1 (sv) * 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning
CN102357259A (zh) * 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
JP6297029B2 (ja) * 2012-05-31 2018-03-20 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 多様な官能基を有する粒子による免疫グロブリンｇ調製物のクロマトグラフィー精製
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
CN113754757A (zh) * 2021-07-01 2021-12-07 华兰生物工程股份有限公司 一种人纤维蛋白原的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
IE73210B1 (en) * 1990-01-24 1997-05-07 Warner Lambert Co Process for the production of thrombin and high purity thrombin preparation thereby obtained
EP0443724B1 (en) * 1990-02-20 1999-03-17 Baxter International Inc. Viral-safe purified human thrombin
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
DE4137996A1 (de) * 1991-11-19 1993-05-27 Behringwerke Ag Verfahren zur herstellung eines virussicheren thrombinkonzentrates
AT397390B (de) * 1992-04-06 1994-03-25 Immuno Ag Verfahren zur spaltung von proteinen
GB9503750D0 (en) * 1995-02-24 1995-04-12 Common Services Agency Thrombin preparation
AT500670A1 (de) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung
US6245548B1 (en) * 2000-03-09 2001-06-12 American National Red Cross Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material

Also Published As

Publication number Publication date
DE60311990T2 (de) 2007-11-08
BR0312522A (pt) 2005-04-19
IL165989A (en) 2010-11-30
DE60311990D1 (de) 2007-04-05
GB0216002D0 (en) 2002-08-21
NZ537502A (en) 2007-12-21
WO2004007707A1 (en) 2004-01-22
IL201146A (en) 2011-05-31
BRPI0312522B1 (pt) 2019-01-02
EP1520018A1 (en) 2005-04-06
PT1520018E (pt) 2007-04-30
BRPI0312522B8 (pt) 2021-05-25
AU2003244858A1 (en) 2004-02-02
US20060134769A1 (en) 2006-06-22
CA2491718C (en) 2013-10-22
ATE354648T1 (de) 2007-03-15
CA2491718A1 (en) 2004-01-22
US8435779B2 (en) 2013-05-07
AU2003244858B2 (en) 2008-01-31
ES2282644T3 (es) 2007-10-16
MXPA05000393A (es) 2005-07-22
JP2005532073A (ja) 2005-10-27
EP1520018B1 (en) 2007-02-21
NO20050090L (no) 2005-04-08
JP4445386B2 (ja) 2010-04-07
PL374747A1 (en) 2005-10-31
ECSP055586A (es) 2005-07-06
PL208219B1 (pl) 2011-03-31
CY1107632T1 (el) 2013-04-18

Similar Documents

Publication Publication Date Title
NO20050090L (no) Fremgangsmate for fremstilling av et virus-inaktivert trombinpreparat
BRPI0013885B8 (pt) comprimidos aperfeiçoados
WO2003104473A8 (de) Galactosyl-isomalt, verfahren zu seiner herstellung und verwendung
IL165988A0 (en) Process for the preparation of fibrinogen
HK1078588A1 (en) Process to prepare eplerenone
AU2002358667A1 (en) Scented polymer capsules and the production thereof
MXPA03010322A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE POLIISOCIANATOS.
MXPA03004986A (es) Proceso para preparar polimeros de emulsion con alta pureza.
NO20040766L (no) Fremgangsmate for fremstilling av glykopeptidfosfonatderivater.
AU2002326925A1 (en) Process for preparing protease inhibitor intermediates
GB2428959A (en) Process for preparation of expanded millet
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
MXPA03010498A (es) Proceso para la preparacion de imipenem.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA04000623A (es) Derivados de tetrahidropiridazina y su uso como pesticidas.
MXPA05003881A (es) Preparacion de compuestos triazospiro.
MY127289A (en) Caloporoside derivatives, process for the preparation thereof, and the use thereof
MY119688A (en) Use of arylguanidinium xanthogenates as vulcanization accelerators and process for the production thereof
AU6584601A (en) Method for producing indols
IL161800A0 (en) Method for the production of desclarithromycin, and intermediateproducts
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine
MXPA02011064A (es) Proceso para la preparacion de 2,3-pentandiona.
UA32372A (uk) Спосіб виробництва порошкоподібного соусу
UA66774C2 (uk) Спосіб виготовлення виробів з січеного м'яса
TW200420553A (en) Process for the synthesis of 3, 3a, 6, 6a-tetrahydro-2H-cyclopentan[b]furan-2-one